HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y-N Sun Selected Research

Capecitabine (Xeloda)

3/2013Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y-N Sun Research Topics

Disease

3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2014 - 09/2011
2Neoplasms (Cancer)
08/2017 - 03/2013
1Intracranial Hemorrhages (Intracranial Hemorrhage)
06/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018
1Leukemia
09/2015
1Adenocarcinoma
03/2013
1Lymphoma (Lymphomas)
11/2008
1Lethargy
11/2008
1Headache (Headaches)
11/2008
1Fatigue
11/2008
1Nausea
11/2008

Drug/Important Bio-Agent (IBA)

4motesanib diphosphateIBA
04/2014 - 11/2008
2trebananibIBA
08/2017 - 03/2013
2Carboplatin (JM8)FDA LinkGeneric
11/2012 - 09/2011
2Bevacizumab (Avastin)FDA Link
11/2012 - 09/2011
2Paclitaxel (Taxol)FDA LinkGeneric
11/2012 - 09/2011
1Toll-Like Receptors (Toll-Like Receptor)IBA
06/2019
1JNK Mitogen-Activated Protein KinasesIBA
06/2019
1splenotritin (TP3)IBA
01/2018
1Prednisone (Sone)FDA LinkGeneric
01/2018
1blinatumomabIBA
09/2015
1Cisplatin (Platino)FDA LinkGeneric
03/2013
1TIE-2 Receptor (Receptor, TIE 2)IBA
03/2013
1Capecitabine (Xeloda)FDA Link
03/2013
1GemcitabineFDA Link
11/2008